Opioids
More on Opioids
Washington, D.C. (Mar. 5, 2021)—Yesterday, Committee on Oversight and Reform Chairwoman Carolyn B. Maloney, Committee on Oversight and Reform Vice Chair Jimmy Gomez, and Committee Member Mark DeSaulnier sent letters to four companies seeking information about their plans to use a CARES Act tax provision—meant to help companies struggling during the coronavirus pandemic—to increase tax deductions for litigation costs related to the company's role in the U.S. opioid crisis.
Washington, D.C. (Dec. 18, 2020)—Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, held a hearing to examine the role of Purdue Pharma and members of the Sackler family in fueling the nationwide opioid epidemic for decades by pushing Purdue executives to flood the market with the highly addictive painkiller OxyContin.
Chairwoman Maloney issued the following statement at the end of hearing:
Washington D.C. (Dec. 14, 2020)—On Thursday, Dec. 17, 2020, at 9:00 a.m., Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, will hold a virtual hearing to examine the role of Purdue Pharma and members of the Sackler family in fueling the nationwide opioid epidemic for decades by pushing Purdue executives to flood the market with the highly addictive painkiller OxyContin.
Washington, D.C. (Dec. 8, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, sent letters informing lawyers for Dr. Richard Sackler, Mr. David Sackler, Dr. Kathe Sackler, and Mr. Mortimer D.A. Sackler that the Committee will hold a hearing next week on the role of Purdue Pharma and the Sackler family in fueling the opioid epidemic. Purdue CEO Craig Landau has also been invited.
| Washington, D.C. (Nov. 25, 2020)—Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, invited Craig Landau, the President and CEO of Purdue Pharma L.P., and four members of the Sackler family to testify at a hearing next month on their role in fueling the opioid epidemic. |
Washington, D.C. (Oct. 27, 2020)— Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Committee Member Rep. Mark DeSaulnier released documents obtained by the Committee as part of its investigation into Purdue Pharma and members of the Sackler family, who have owned a controlling share of Purdue since 1952.
WASHINGTON – Today, Congressman Rouda (D-CA-48) and Congressman Ted Budd (R-NC-13), along with 35 Representatives, introduced the bipartisan Drug-Free Communities Pandemic Relief Act. This bill would help ensure Drug-Free Communities coalitions can continue to operate and reduce youth substance use during the COVID-19 pandemic.
Washington, D.C. (June 25, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after the independent and nonpartisan Government Accountability Office (GAO) issued its first report on oversight of the CARES Act:
Washington, D.C. (Feb. 3, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, announced that James Carroll, the Director of the Office of the National Drug Control Policy (ONDCP), has agreed to testify at a hearing on February 27, 2020. The hearing will examine the recently released 2020 National Drug Control Strategy and the Administration's response to the ongoing drug epidemic.
Chairwoman Maloney issued a statement following the release of the 2020 National Drug Control Strategy today: